Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AMRX · against 201 other Healthcare companies of similar size
Ranked #196 of 202 · scores higher than 3% of peers · safety percentile 5
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)16 peers with a safety percentile of 0–9, including AMRX · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | AMRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 197 reported | 23.87× | 0.27× | 1% | 33% | |
| BetaLower is better · 203 reported | 1.22 | 0.58 | 18% | 33% | |
| Current ratioHigher is better · 194 reported | 2.21× | 2.81× | 39% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 3.6B USD | 99 | ||
| 4 | 10.1B EUR (≈$11.1B) | 99 | ||
| 5 | 9.0B USD | 98 | 51 | |
| 192 | 4.2B USD | 7 | 41 | |
| 193 | 11.6B USD | 6 | 57 | |
| 194 | 8.8B USD | 6 | 31 | |
| 195 | 7.3B USD | 6 | 32 | |
| 196 | 7.0B USD | 5 | 57 | |
| 197 | 4.3B USD | 3 | 69 | |
| 198 | 3.6B USD | 3 | 43 | |
| 199 | 4.6B USD | 3 | 61 | |
| 200 | 14.0B USD | 2 | 31 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score